Archive
FTSE100 falls as oil hopes rise; Glaxo bid talk swirls
Britain's blue chips closed the afternoon session lower after uninspiring UK economic data and as energy powerhouse Centrica weighed.
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 35 of 38
Trending: Johnson & Johnson mulling Glaxo bid?
Open Outcrier tweets that there is “vague takeover chatter” concerning a takeover of drugs giant GlaxoSmithKline by healthcare behemoth Johnson & Johnson.
Archive
JP Morgan prefers precious metals over bulks
Heavyweight JP Morgan Cazenove becomes the latest house to paint a gloomy picture for mining stocks in 2016 but says it prefers precious metals to bulk commodities in a note on Monday.
Archive
Barclays pharma experts bullish on Shire and Glaxo
Shares in drug giants Glaxo and Shire should stay in fine heath this year, Barclays says
FTSE100 falls but bid talk lifts Smith & Nephew
Santa rally hopes faded but S&N takeover chatter provided interest
FTSE100 eases; Glaxo buys HIV assets
The FTSE100 lost around 36 points to 6,605 by lunch after three consecutive days of gains.
FTSE rises; Supergroup makes a super start to the year
The FTSE100, which is down around 7.5% on the year, rose almost 1%, or 59 points, to 6,076 by lunch.
Investments and investor services
FTSE100 moves firmly away from three-year lows
The index appears likely to end its run of eight straight daily falls,
FTSE100 registers triple digit gains
The index appears likely to end its run of eight straight daily falls,
Investments and investor services
FTSE100 rally gives investors something to cheer
The FTSE 100 Index was around 1.5%, or 90 points, higher to 5,964
Investments and investor services
FTSE100 gains 25, Shire rises on M&A chatter
The FTSE100 could only manage a 25 point gain to 6,420.
FTSE 100 consolidates early gains
FTSE 100 was 21 points higher at 6,416 ahed of the US opening
GlaxoSmithKline pins future on 40 new drugs
The UK pharma giant may file up to 20 treatments with regulators before 2020.
Archive
Deutsche upbeat on Glaxo; lifts price target
Broker heavyweight Deutsche is upbeat on drugs giant GlaxoSmithKline on Friday and has punted up the target price to 1,500p from 1,450p.
Investments and investor services
Glaxo's study results more bad than good reckons JP Morgan
Strong Phase III data for its Shingrix shingles vaccine in patients over 70 years follow encouraging data from the 50 years and older study.
Investments and investor services
FTSE 100 gets afternoon boost from Glaxo
Stocks were on an upward trend, helped by a recovery by commodity plays
GlaxoSmithKline tops expectations
After playing swapsies with Novartis earlier this year Glaxo said it remains on track to resume earnings growth next year.
London's shares remain slightly higher at lunch
GlaxoSmithKline, BT and British American Tobacco led the way higher
Investments and investor services
Risers & Fallers: Opsec Security, PeerTV, Plexus, Plutus Powergen, DJI Holdings and more...
Below are the main news-driven share price movements at 4pm.